Marval O’Farrell Mairal combines its full-service capability with deep life sciences sector expertise to provide life sciences clients with highly specialised advice on M&A deals, regulation, compliance, contractual matters, IP and litigation. The firm is a regular presence on big-ticket M&A deals in the sector and is also noted for is track record supporting international life sciences companies entering the Argentine market. Team head Martín Mosteirin is a stand-out practitioner in the field and known for his ‘extensive experience’ of the industry. Senior associate Camila Leone rejoined the practice in March 2023 having completed an LLM in health law at Georgetown. Fellow associate Carolina Andrea Ramirez is also focused on the life sciences, particularly regulatory strategies and compliance.

The Allende & Brea life sciences team advises clients in the pharmaceutical, medical devices, biotechnology, food, beverages and cosmetics industries on daily operations, regulatory matters, M&A deals, and licensing and distribution agreements. Recent mandates have seen the team assist clients with regulatory clearances for the import, export, sale and distribution of medical products in Argentina, clinical trials, and healthcare packaging and labelling. The practice is co-led by Maria Morena Del Rio, who focuses on regulatory matters in relation to the life sciences sector; and Fernando Martínez Zuviría, who has experience working with the National Administration of Drugs, Foods and Medical Devices (ANMAT) and the National and Provincial Ministries of Health.

Life sciences clients call on Beccar Varela for support on commercial matters, IP, litigation, and M&A related to the industry. The team is well-versed in the regulatory aspects of clinical trials and drug approvals, and main industry players also turn to the practice for advice on orphan drugs, the country’s exception access regime for pharmaceutical products, and medicinal cannabis' matters. Dynamic young partner Ana Andrés leads the team and has already built a strong reputation in the market for her ‘very good knowledge of the industry’. Life sciences and corporate-focused associate Julieta González provides primary support.

Core areas of work for the Bruchou & Funes de Rioja life sciences practice include commercial agreements, strategic partnerships, litigation and M&A; as well as trade mark, patent and other IP matters. The practice covers the pharmaceutical, health, personal hygiene, cosmetics, biotechnology and medical device segments, and is co-led by corporate and M&A lawyer Estanislao Olmos (who focuses on transactional work and commercial agreements in the sector), and IP expert Dámaso Pardo. Promoted to the partnership in March 2022, public law specialist Juan Zocca advises on lifescience-related administrative matters - particularly regulatory issues related to medicinal cannabis, drugs, healthcare and health technologies, the registration of products and companies before the Argentine Health Authority (ANMAT), and the application of the Chemical Precursors Regime to pharmaceutical companies, among other matters.

Alfaro-Abogados’ multidisciplinary practice provides advice on regulatory, M&A, marketing and administrative matters to clients in the healthcare, pharmaceutical, veterinary, agriculture, fisheries and food industries. Clients also turn to the firm for support on data protection, tax and patent prosecution, as well as litigation. Managing partner and administrative law expert Carlos Alfaro co-leads the team alongside transactional and regulatory lawyer Sebastian Rodrigo, and M&A-focused practitioner Pedro Mazer.

The Bomchil life sciences practice advises local and international clients on clinical trials, telemedicine, tobacco-free products and clinical practice guidelines, as well as handling complex medical malpractice litigation and class actions, and providing pre-trial advice to clinics and medical services' providers in order to mitigate risk. Litigation partner Martín Girotti co-leads the practice with fellow contentious specialist, Melisa Romero, who was raised to the partnership in January 2023; she focuses on medical malpractice proceedings and has also been advising clients on cases arising from the adverse effects of Covid-19 vaccines and clinical trials.